India accounts for more than 1 in 4 of all active TB cases, including almost 1.20 lakh cases of drug-resistant forms of TB.

Fujifilm India Pvt Ltd, a multinational manufacturer of medical devices, has announced the launch of a national campaign to raise awareness and eliminate the spread of tuberculosis in India.

As part of the campaign titled ‘Never Stop: Screening to Reduce Time to Diagnosis’, the medical device maker aims to increase awareness of TB and identify people with TB symptoms among vulnerable and marginalized sections of the company by introducing a mobile van with an x-ray as well as a field team and community volunteers.

In line with the government’s mission to free India from tuberculosis by 2025, Fujifilm India has launched this campaign in association with the National TB Elimination Program (NTEP). Through its existing network of laboratories, NTEP will assist in tuberculosis screening and provide anti-tuberculosis drugs according to program guidelines. The International Union Against Tuberculosis and Lung Disease (The Union), a world leader in lung health, will provide technical support through the United States Agency for International Development (USAID iDEFEAT TB Project .

Speaking at the launch of the campaign, Koji Wada, Managing Director of Fujifilm India Pvt Ltd, said: “Tuberculosis is a major and growing health problem in India, many people lose their lives every year. At Fujifilm, we’ve always been committed to providing the best healthcare technologies and innovations to make this world a better and healthier place.

Dr Sudarsan Mandal, DDG TB Central TB Division, said: “India accounts for a quarter of the global TB burden and continues to top the list of TB patients, according to a report released by Global Tuberculosis Report 2020. Our association with Fujifilm India has a head start in the public and private sectors to strengthen tuberculosis (TB) diagnostic capacity with innovative equipment from Fujifilm which will ultimately result in an increase in tuberculosis (TB). the identification of tuberculosis cases and thus help to eliminate tuberculosis in the country by 2025.

The campaign is also part of the Corporate TB Pledge (CTP), a USAID-supported initiative launched with the Indian government in 2019 to galvanize the Indian business sector to fight TB, raise awareness of TB as a disease curable and, ultimately, improve health outcomes from TB.

Through the campaign, Fujifilm will deliver door-to-door TB awareness and provide instant interpretation of mobile digital x-rays using Qure.ai’s artificial intelligence solution. This community-based tuberculosis screening initiative will target migrant workers, rural and semi-urban slum dwellers in and around industrial pockets in selected areas of 25 districts across states, UT Chandigarh, Punjab, Himachal Pradesh, Uttar Pradesh, Uttarakhand, Bihar, West Bengal, Chhattisgarh, Madhya Pradesh and Rajasthan for the next nine months.

The project partnered with Apollo Tires Foundation, Ambuja Cement Foundation, GAIL India and TCI Foundation for community mobilization in the field, sputum collection and transport. About nine lakh people will be reached through large-scale publicized activities to identify symptoms of taking x-rays and subsequent tuberculosis tests. Existing CTP partners will facilitate community sensitization, mobilization and follow-up testing.

About The Author

Related Posts